Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Seiichiro YAMASAKI
Catabolism of Very Low Density Lipoprotein; Especially Change of Interaction of Lipoproteins on Heparin Infusion
The Journal of Japan Atherosclerosis Society
An Analysis and Identification of Urinary Steroids From Normals and Patients With 21-Hydroxylase Deficiency and Urinary Excretion Patterns
Folia Endocrinologica Japonica
Related publications
Glycation of Very Low Density Lipoprotein From Rat Plasma Impairs Its Catabolism
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effects of Low-Dose Oral Contraceptives on Very Low-Density and Low-Density Lipoprotein Metabolism
Obstetrical and Gynecological Survey
Medicine
Gynecology
Obstetrics
Enhancement of the Binding of Triglyceride-Rich Lipoproteins to the Very Low Density Lipoprotein Receptor by Apolipoprotein E and Lipoprotein Lipase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Development of an Integrated Model for Analysis of the Kinetics of Apolipoprotein B in Plasma Very Low Density Lipoproteins, Intermediate Density Lipoproteins, and Low Density Lipoproteins.
Journal of Clinical Investigation
Medicine
The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Separation of Apolipoproteins of Human Very Low Density Lipoproteins by Chromatofocusing
Clinical Chemistry and Laboratory Medicine
Biochemistry
Medicine
Clinical Biochemistry
Fenofibrate Reduces Low Density Lipoprotein Catabolism in Hypertriglyceridemic Subjects
Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
Pre-Beta-Very Low Density Lipoproteins as Precursors of Beta-Very Low Density Lipoproteins. A Model for the Pathogenesis of Familial Dysbetalipoproteinemia (Type III Hyperlipoproteinemia).
Journal of Clinical Investigation
Medicine
A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low-Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
